site stats

Pear therapeutics investor relations

WebFind the latest Pear Therapeutics, Inc. (PEAR) stock quote, history, news and other vital information to help you with your stock trading and investing. WebJun 7, 2024 · Pear Therapeutics has set out its approach to clinical data and market access as it seeks a more than fivefold increase in revenue for its prescription digital therapeutics in 2024. The Boston-based company used its virtual investor day to share clinical data and evidence on its products, including the results of a study published in Advances ...

EX-99.5 - SEC

WebNov 15, 2024 · Pear Therapeutics, a specialist in prescription digital therapeutics (PDTs), is going through another round of layoffs after posting 3Q22 earnings. The Boston, MA-based company said it is cutting about 22% of its staff - impacting 59 employees. Although Pear grew its revenue 24% quarter-over-quarter to $4.1 million – which was slightly higher ... WebMar 31, 2024 · At the end of the latest market close, Pear Therapeutics Inc. (PEAR) was valued at $0.26. In that particular session, Stock kicked-off at the price of $0.2425 while reaching the peak value of $0.285 and lowest value recorded on the day was $0.2425. The stock current value is $0.25.Recently in News on March 17, 2024, Pear Therapeutics … bbbank baukredit https://eventsforexperts.com

Pear Therapeutics Inc. (PEAR): Investors are paying attention to …

WebJun 22, 2024 · TOKYO, June 22 (Reuters) - SoftBank-backed healthcare startup Pear Therapeutics has agreed to go public through a merger with Thimble Point Acquisition … WebApr 13, 2024 · Pear Therapeutics said it would grow from $4 million in 2024 to a whopping $125 million by the end of 2024. ... the stock sale had yielded just $1 million and it was … WebJun 22, 2024 · Pear shareholders, Thimble Point shareholders, and PIPE investors will hold shares in the combined company, Pear Holdings Corp., to be led by Pear’s current management team, and expected to... davoli marina maps

Investor FAQs - Pear Therapeutics, Inc.

Category:Annual Reports - Pear Therapeutics, Inc.

Tags:Pear therapeutics investor relations

Pear therapeutics investor relations

Pear sets out payer strategy as it seeks to quadruple prescriptions …

WebThe Board of Directors of Pear Therapeutics, Inc. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. WebNov 14, 2024 · Investors Corporate Profile Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs).

Pear therapeutics investor relations

Did you know?

WebPear Therapeutics (US) On April 7, 2024, Pear Therapeutics Inc. and its wholly owned subsidiary, Pear Therapeutics (US), Inc. (collectively, the “Debtors”) each voluntarily filed for Chapter 11 bankruptcy protection in the United States Bankruptcy Court for the District of Delaware (Case Nos. 23-10429; 23-20430). WebJan 19, 2024 · Pear shed light on the level of interest in digital therapeutics last year when it raised $175 million in a merger with a special purpose acquisition company. In making the case for the SPAC combination, Pear set out plans to grow its revenues from $4 million in 2024 to $125 million in 2024.

WebApr 7, 2024 · BOSTON – April 7, 2024 – Pear Therapeutics, Inc. (Nasdaq: PEAR) (“the Company”), a company focused on developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that the Company and its wholly owned subsidiary, Pear Therapeutics (US), Inc. (collectively, the … WebPear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. Search Crunchbase. ... 648 Number of Organizations • $46.7B Total Funding Amount • 1,899 Number of Investors. Track . United States Pharmaceutical Companies .

WebJul 20, 2024 · That’s where the SPAC deal comes in. Pear is merging with Thimble Point Acquisition Corp, a blank check company associated with Hyatt Hotel billionaire heiress Karen Pritzker. Following the completion of a reverse merger planned for the second half of 2024, Pear will have access to gross proceeds of around $400 million. WebFeb 27, 2024 · Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and …

WebJun 22, 2024 · Pear Prescription Digital Therapeutics (PDT) Digest Investors Careers Our Values Our Culture Open Positions Contact Us Pear Therapeutics (US) Press Releases Pear Therapeutics – Thimble Point Acquisition Corp. Conference Call June 22, 2024 at 8:30 a.m. ET Attend the Call → Download the presentation Back Pear Therapeutics (US) Boston 200 …

WebMar 14, 2024 · Pear Therapeutics, Inc. Class A Common Stock (PEAR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. davoli sncWebJun 22, 2024 · Pear shareholders, Thimble Point shareholders, and PIPE investors will hold shares in the combined company, Pear Holdings Corp., to be led by Pear’s current … bbbank dauerauftragWebMar 17, 2024 · Pear’s stock closed at 39 cents a share on Friday, down 34% from 59 cents at yesterday’s close. The Boston-based company had raised $250 million in venture funding from investors including ... bbbank debitkarte